Life-threatening metastasis was suppressed by trastuzumab containing regimen in a patient with Her2-negative breast cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-06-23

AUTHORS

Kazunori Takahashi, Hiroshi Nakagomi, Masayuki Inoue, Yuko Nakayama, Kazushige Furuya, Masahiro Maruyama, Atsushi Takano, Hidemitsu Sugai, Masao Hada, Yoshiaki Miyasaka, Kenji Amemiya, Toshio Oyama

ABSTRACT

A 49-year-old female was referred to our hospital with left breast cancer and subsequently underwent mastectomy and axillary dissection. The pathological findings showed invasive breast cancer with lymph node metastasis (2/22), nuclear grade 3, ER (6+) PgR (2+) for the Allred score, and Her2 (2+) in an immunohistochemistry. We determined the subtype of Her2-negative breast cancer according to the fluorescent in situ hybridization results, as follows: Her2/CEP17 ratio 1.1 < 2.0. The patient received the EC regimen followed by docetaxel, and toremifene was subsequently administered. One year after the operation, the CA15-3 level was elevated at 50 ng/ml, and CT revealed liver metastases. Disease progression was not suppressed by paclitaxel containing regimen and eribulin. Then, we subsequently sought to determine whether the metastatic lesion showed the Her2 expression. Although the Her2 expression in the axillary lymph node metastases showed heterogeneous staining, the results were judged as Her2 (1+) according to the ASCO/CAP guidelines. We decided to administer trastuzumab and docetaxel due to the patient’s life-threatening status, after which the CA15-3 level decreased and the symptom of fatigue improved. A total of 9 cycles of trastuzumab and docetaxel were administered, followed by maintenance trastuzumab continued to the present time. Physicians should be aware of the statement in the ASCO/CAP guidelines that the clinical decision to ultimately consider Her2-targeted therapy should be individualized according to the patient’s status. More... »

PAGES

61-65

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13691-015-0228-4

DOI

http://dx.doi.org/10.1007/s13691-015-0228-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1045321767

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31149426


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takahashi", 
        "givenName": "Kazunori", 
        "id": "sg:person.0630613007.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630613007.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakagomi", 
        "givenName": "Hiroshi", 
        "id": "sg:person.01152576336.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152576336.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Inoue", 
        "givenName": "Masayuki", 
        "id": "sg:person.01354217107.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354217107.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakayama", 
        "givenName": "Yuko", 
        "id": "sg:person.01301235631.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301235631.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Furuya", 
        "givenName": "Kazushige", 
        "id": "sg:person.01265174206.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265174206.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maruyama", 
        "givenName": "Masahiro", 
        "id": "sg:person.01327356207.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327356207.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takano", 
        "givenName": "Atsushi", 
        "id": "sg:person.0773611633.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773611633.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sugai", 
        "givenName": "Hidemitsu", 
        "id": "sg:person.01015045552.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01015045552.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hada", 
        "givenName": "Masao", 
        "id": "sg:person.01224023431.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224023431.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyasaka", 
        "givenName": "Yoshiaki", 
        "id": "sg:person.0603752107.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603752107.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Pathology, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Amemiya", 
        "givenName": "Kenji", 
        "id": "sg:person.01271466715.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271466715.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Pathology, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oyama", 
        "givenName": "Toshio", 
        "id": "sg:person.011405362052.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011405362052.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/modpathol.2008.34", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007014320", 
          "https://doi.org/10.1038/modpathol.2008.34"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12032-013-0798-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001424934", 
          "https://doi.org/10.1007/s12032-013-0798-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-06-23", 
    "datePublishedReg": "2015-06-23", 
    "description": "Abstract\nA 49-year-old female was referred to our hospital with left breast cancer and subsequently underwent mastectomy and axillary dissection. The pathological findings showed invasive breast cancer with lymph node metastasis (2/22), nuclear grade 3, ER (6+) PgR (2+) for the Allred score, and Her2 (2+) in an immunohistochemistry. We determined the subtype of Her2-negative breast cancer according to the fluorescent in situ hybridization results, as follows: Her2/CEP17 ratio 1.1\u00a0<\u00a02.0. The patient received the EC regimen followed by docetaxel, and toremifene was subsequently administered. One year after the operation, the CA15-3 level was elevated at 50\u00a0ng/ml, and CT revealed liver metastases. Disease progression was not suppressed by paclitaxel containing regimen and eribulin. Then, we subsequently sought to determine whether the metastatic lesion showed the Her2 expression. Although the Her2 expression in the axillary lymph node metastases showed heterogeneous staining, the results were judged as Her2 (1+) according to the ASCO/CAP guidelines. We decided to administer trastuzumab and docetaxel due to the patient\u2019s life-threatening status, after which the CA15-3 level decreased and the symptom of fatigue improved. A total of 9 cycles of trastuzumab and docetaxel were administered, followed by maintenance trastuzumab continued to the present time. Physicians should be aware of the statement in the ASCO/CAP guidelines that the clinical decision to ultimately consider Her2-targeted therapy should be individualized according to the patient\u2019s status.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13691-015-0228-4", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1136680", 
        "issn": [
          "2192-3183"
        ], 
        "name": "International Cancer Conference Journal", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "keywords": [
      "HER2-negative breast cancer", 
      "ASCO/CAP guidelines", 
      "life-threatening status", 
      "CA15-3 levels", 
      "lymph node metastasis", 
      "breast cancer", 
      "node metastasis", 
      "CAP guidelines", 
      "HER2 expression", 
      "axillary lymph node metastasis", 
      "nuclear grade 3", 
      "cycles of trastuzumab", 
      "left breast cancer", 
      "invasive breast cancer", 
      "symptoms of fatigue", 
      "life-threatening metastases", 
      "HER2/CEP17", 
      "ER-PgR", 
      "EC regimen", 
      "maintenance trastuzumab", 
      "underwent mastectomy", 
      "axillary dissection", 
      "liver metastases", 
      "pathological findings", 
      "metastatic lesions", 
      "disease progression", 
      "Allred score", 
      "grade 3", 
      "patient status", 
      "trastuzumab", 
      "clinical decision", 
      "metastasis", 
      "regimen", 
      "cancer", 
      "heterogeneous staining", 
      "docetaxel", 
      "HER2", 
      "patients", 
      "situ hybridization results", 
      "status", 
      "guidelines", 
      "mastectomy", 
      "toremifene", 
      "eribulin", 
      "hospital", 
      "therapy", 
      "immunohistochemistry", 
      "lesions", 
      "expression", 
      "symptoms", 
      "subtypes", 
      "physicians", 
      "paclitaxel", 
      "dissection", 
      "progression", 
      "CT", 
      "staining", 
      "CEP17", 
      "levels", 
      "PgR", 
      "scores", 
      "total", 
      "females", 
      "hybridization results", 
      "years", 
      "fatigue", 
      "findings", 
      "present time", 
      "results", 
      "time", 
      "fluorescent", 
      "cycle", 
      "statements", 
      "decisions", 
      "operation", 
      "patient\u2019s life-threatening status"
    ], 
    "name": "Life-threatening metastasis was suppressed by trastuzumab containing regimen in a patient with Her2-negative breast cancer", 
    "pagination": "61-65", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1045321767"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13691-015-0228-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31149426"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13691-015-0228-4", 
      "https://app.dimensions.ai/details/publication/pub.1045321767"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_676.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13691-015-0228-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13691-015-0228-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13691-015-0228-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13691-015-0228-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13691-015-0228-4'


 

This table displays all metadata directly associated to this object as RDF triples.

224 TRIPLES      22 PREDICATES      104 URIs      94 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13691-015-0228-4 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Nff0b9871ddf44cadb25264f9af390ec8
4 schema:citation sg:pub.10.1007/s12032-013-0798-y
5 sg:pub.10.1038/modpathol.2008.34
6 schema:datePublished 2015-06-23
7 schema:datePublishedReg 2015-06-23
8 schema:description Abstract A 49-year-old female was referred to our hospital with left breast cancer and subsequently underwent mastectomy and axillary dissection. The pathological findings showed invasive breast cancer with lymph node metastasis (2/22), nuclear grade 3, ER (6+) PgR (2+) for the Allred score, and Her2 (2+) in an immunohistochemistry. We determined the subtype of Her2-negative breast cancer according to the fluorescent in situ hybridization results, as follows: Her2/CEP17 ratio 1.1 < 2.0. The patient received the EC regimen followed by docetaxel, and toremifene was subsequently administered. One year after the operation, the CA15-3 level was elevated at 50 ng/ml, and CT revealed liver metastases. Disease progression was not suppressed by paclitaxel containing regimen and eribulin. Then, we subsequently sought to determine whether the metastatic lesion showed the Her2 expression. Although the Her2 expression in the axillary lymph node metastases showed heterogeneous staining, the results were judged as Her2 (1+) according to the ASCO/CAP guidelines. We decided to administer trastuzumab and docetaxel due to the patient’s life-threatening status, after which the CA15-3 level decreased and the symptom of fatigue improved. A total of 9 cycles of trastuzumab and docetaxel were administered, followed by maintenance trastuzumab continued to the present time. Physicians should be aware of the statement in the ASCO/CAP guidelines that the clinical decision to ultimately consider Her2-targeted therapy should be individualized according to the patient’s status.
9 schema:genre article
10 schema:inLanguage en
11 schema:isAccessibleForFree true
12 schema:isPartOf N0bc8d569efcb4d39be5a99329d29c723
13 N559d3decb9994f6d8098fc53e702e288
14 sg:journal.1136680
15 schema:keywords ASCO/CAP guidelines
16 Allred score
17 CA15-3 levels
18 CAP guidelines
19 CEP17
20 CT
21 EC regimen
22 ER-PgR
23 HER2
24 HER2 expression
25 HER2-negative breast cancer
26 HER2/CEP17
27 PgR
28 axillary dissection
29 axillary lymph node metastasis
30 breast cancer
31 cancer
32 clinical decision
33 cycle
34 cycles of trastuzumab
35 decisions
36 disease progression
37 dissection
38 docetaxel
39 eribulin
40 expression
41 fatigue
42 females
43 findings
44 fluorescent
45 grade 3
46 guidelines
47 heterogeneous staining
48 hospital
49 hybridization results
50 immunohistochemistry
51 invasive breast cancer
52 left breast cancer
53 lesions
54 levels
55 life-threatening metastases
56 life-threatening status
57 liver metastases
58 lymph node metastasis
59 maintenance trastuzumab
60 mastectomy
61 metastasis
62 metastatic lesions
63 node metastasis
64 nuclear grade 3
65 operation
66 paclitaxel
67 pathological findings
68 patient status
69 patients
70 patient’s life-threatening status
71 physicians
72 present time
73 progression
74 regimen
75 results
76 scores
77 situ hybridization results
78 staining
79 statements
80 status
81 subtypes
82 symptoms
83 symptoms of fatigue
84 therapy
85 time
86 toremifene
87 total
88 trastuzumab
89 underwent mastectomy
90 years
91 schema:name Life-threatening metastasis was suppressed by trastuzumab containing regimen in a patient with Her2-negative breast cancer
92 schema:pagination 61-65
93 schema:productId N6f080b9c871941c381d162be15793530
94 N807f370d2a1c40d59e23bb1dcd6cb995
95 Nd5ae647c398542c0b77c6d60bd97eb10
96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045321767
97 https://doi.org/10.1007/s13691-015-0228-4
98 schema:sdDatePublished 2022-01-01T18:38
99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
100 schema:sdPublisher N802b4450bdb84d629c549cc408cfcfdb
101 schema:url https://doi.org/10.1007/s13691-015-0228-4
102 sgo:license sg:explorer/license/
103 sgo:sdDataset articles
104 rdf:type schema:ScholarlyArticle
105 N05c53273ca6a49de86caa5ebd462ed47 rdf:first sg:person.0603752107.03
106 rdf:rest N89030eebc82444b7999f013897a22e32
107 N0bc8d569efcb4d39be5a99329d29c723 schema:issueNumber 1
108 rdf:type schema:PublicationIssue
109 N0c91a29de85e4eafb904ec25b788ad0a rdf:first sg:person.01354217107.78
110 rdf:rest N79c2585adc3c4718bb9d40207f2ae15d
111 N179ae1eea16843a0ba4aea684bf6b6e7 rdf:first sg:person.01015045552.72
112 rdf:rest Nad05cd757aed4aea8d603bf68b0243e6
113 N3ccf19e7ae0d4a4fa03702ef92357d80 rdf:first sg:person.01265174206.02
114 rdf:rest N7aeb4b613cd5440cb401fe12ff95abfd
115 N559d3decb9994f6d8098fc53e702e288 schema:volumeNumber 5
116 rdf:type schema:PublicationVolume
117 N6f080b9c871941c381d162be15793530 schema:name doi
118 schema:value 10.1007/s13691-015-0228-4
119 rdf:type schema:PropertyValue
120 N79c2585adc3c4718bb9d40207f2ae15d rdf:first sg:person.01301235631.15
121 rdf:rest N3ccf19e7ae0d4a4fa03702ef92357d80
122 N7aeb4b613cd5440cb401fe12ff95abfd rdf:first sg:person.01327356207.01
123 rdf:rest Na9cb35a8bb6e4e74b43c62de9988a139
124 N802b4450bdb84d629c549cc408cfcfdb schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 N807f370d2a1c40d59e23bb1dcd6cb995 schema:name pubmed_id
127 schema:value 31149426
128 rdf:type schema:PropertyValue
129 N89030eebc82444b7999f013897a22e32 rdf:first sg:person.01271466715.07
130 rdf:rest Ne3e1bdc1427548f884e343f756d25042
131 N93e6295e1ec94dfdb4bafbd56c3c64db rdf:first sg:person.01152576336.53
132 rdf:rest N0c91a29de85e4eafb904ec25b788ad0a
133 Na9cb35a8bb6e4e74b43c62de9988a139 rdf:first sg:person.0773611633.23
134 rdf:rest N179ae1eea16843a0ba4aea684bf6b6e7
135 Nad05cd757aed4aea8d603bf68b0243e6 rdf:first sg:person.01224023431.12
136 rdf:rest N05c53273ca6a49de86caa5ebd462ed47
137 Nd5ae647c398542c0b77c6d60bd97eb10 schema:name dimensions_id
138 schema:value pub.1045321767
139 rdf:type schema:PropertyValue
140 Ne3e1bdc1427548f884e343f756d25042 rdf:first sg:person.011405362052.18
141 rdf:rest rdf:nil
142 Nff0b9871ddf44cadb25264f9af390ec8 rdf:first sg:person.0630613007.44
143 rdf:rest N93e6295e1ec94dfdb4bafbd56c3c64db
144 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
145 schema:name Medical and Health Sciences
146 rdf:type schema:DefinedTerm
147 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
148 schema:name Oncology and Carcinogenesis
149 rdf:type schema:DefinedTerm
150 sg:journal.1136680 schema:issn 2192-3183
151 schema:name International Cancer Conference Journal
152 schema:publisher Springer Nature
153 rdf:type schema:Periodical
154 sg:person.01015045552.72 schema:affiliation grid-institutes:grid.417333.1
155 schema:familyName Sugai
156 schema:givenName Hidemitsu
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01015045552.72
158 rdf:type schema:Person
159 sg:person.011405362052.18 schema:affiliation grid-institutes:grid.417333.1
160 schema:familyName Oyama
161 schema:givenName Toshio
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011405362052.18
163 rdf:type schema:Person
164 sg:person.01152576336.53 schema:affiliation grid-institutes:grid.417333.1
165 schema:familyName Nakagomi
166 schema:givenName Hiroshi
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152576336.53
168 rdf:type schema:Person
169 sg:person.01224023431.12 schema:affiliation grid-institutes:grid.417333.1
170 schema:familyName Hada
171 schema:givenName Masao
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224023431.12
173 rdf:type schema:Person
174 sg:person.01265174206.02 schema:affiliation grid-institutes:grid.417333.1
175 schema:familyName Furuya
176 schema:givenName Kazushige
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265174206.02
178 rdf:type schema:Person
179 sg:person.01271466715.07 schema:affiliation grid-institutes:grid.417333.1
180 schema:familyName Amemiya
181 schema:givenName Kenji
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271466715.07
183 rdf:type schema:Person
184 sg:person.01301235631.15 schema:affiliation grid-institutes:grid.417333.1
185 schema:familyName Nakayama
186 schema:givenName Yuko
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301235631.15
188 rdf:type schema:Person
189 sg:person.01327356207.01 schema:affiliation grid-institutes:grid.417333.1
190 schema:familyName Maruyama
191 schema:givenName Masahiro
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327356207.01
193 rdf:type schema:Person
194 sg:person.01354217107.78 schema:affiliation grid-institutes:grid.417333.1
195 schema:familyName Inoue
196 schema:givenName Masayuki
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354217107.78
198 rdf:type schema:Person
199 sg:person.0603752107.03 schema:affiliation grid-institutes:grid.417333.1
200 schema:familyName Miyasaka
201 schema:givenName Yoshiaki
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603752107.03
203 rdf:type schema:Person
204 sg:person.0630613007.44 schema:affiliation grid-institutes:grid.417333.1
205 schema:familyName Takahashi
206 schema:givenName Kazunori
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630613007.44
208 rdf:type schema:Person
209 sg:person.0773611633.23 schema:affiliation grid-institutes:grid.417333.1
210 schema:familyName Takano
211 schema:givenName Atsushi
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773611633.23
213 rdf:type schema:Person
214 sg:pub.10.1007/s12032-013-0798-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1001424934
215 https://doi.org/10.1007/s12032-013-0798-y
216 rdf:type schema:CreativeWork
217 sg:pub.10.1038/modpathol.2008.34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007014320
218 https://doi.org/10.1038/modpathol.2008.34
219 rdf:type schema:CreativeWork
220 grid-institutes:grid.417333.1 schema:alternateName Department of Pathology, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan
221 Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan
222 schema:name Department of Pathology, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan
223 Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan
224 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...